Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma

[Image: see text]

Detalles Bibliográficos
Autores principales: Foureau, David, Bhutani, Manisha, Guo, Fei, Rigby, Katherine, Leonidas, Marina, Tjaden, Elise, Fox, Andee, Atrash, Shebli, Paul, Barry, Voorhees, Peter M., Usmani, Saad Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Researcher
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525140/
https://www.ncbi.nlm.nih.gov/pubmed/34494717
http://dx.doi.org/10.1002/cam4.4254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525140/
https://www.ncbi.nlm.nih.gov/pubmed/34494717
http://dx.doi.org/10.1002/cam4.4254

Ejemplares similares